Dr. Michael Bruce Mizoguchi, MD

Dr. Mizoguchi practices at Humboldt Medical Eye Associates in Eureka, California.

Dr. Mizoguchi's NPI, 1861418808, was assigned on July 14, 2006. Dr. Mizoguchi graduated from Keck School of Medicine of USC in 1998. Dr. Mizoguchi's California license number on file is A70161.

Dr. Mizoguchi's primary practice is Humboldt Medical Eye Associates, at 2434 Harrison Ave, Eureka, CA 95501-3219. The practice phone is (707) 443-5685.

Dr. Mizoguchi's primary practice is Humboldt Medical Eye Associates in Eureka, California. Dr. Mizoguchi is also affiliated with Providence St. Joseph Hospital Eureka. Dmand AI also links Dr. Mizoguchi to 1 more hospital and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mizoguchi practices, 3 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Mizoguchi's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Mizoguchi is board certified in ophthalmology by the American Board of Ophthalmology. Dr. Mizoguchi has a license on file in California.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, cold sores or genital herpes, conjunctivitis, dry eye, eye infection or inflammation and eyelid inflammation among the conditions Dr. Mizoguchi treats.

CMS data shows 11,509 Medicare services from Dr. Mizoguchi across 25 procedure codes in 2024, for 2,303 Medicare patients. Medicare paid $1,071,339 for them.

CMS counts 2,303 Medicare patients who saw Dr. Mizoguchi in 2024. The largest group is 75 to 84, with 1,061 patients. 64% of them have high blood pressure, and 64% have high cholesterol. 17% are also on Medicaid. Their average risk score is 0.98, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Mizoguchi's median patient age at 77, with 63% women.

In 2024, Dr. Mizoguchi wrote 4,057 Medicare Part D claims for 711 patients. 61% of them were for generic drugs. CMS names the drug for 3,933 of them, across 30 drugs with 11 or more claims each, at $320,310 in total drug cost. In 2023, CMS named 3,462 claims across 24 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Mizoguchi for performance year 2024, reported as part of a group. Dr. Mizoguchi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 475 procedures of cataract surgery by Dr. Mizoguchi, more than 95% of the clinicians it reports for that procedure.

Dmand AI links 1 paper to Dr. Mizoguchi.

CMS Open Payments shows 29 general payments to Dr. Mizoguchi from 14 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 93% of the total. Carl Zeiss Meditec, Inc. paid the most, $214.

Dmand AI lists 2 awards for Dr. Mizoguchi, most recently AAO Fellow in 2012.

Dr. Mizoguchi graduated from Keck School of Medicine of USC in 1998. Dr. Mizoguchi is a member of AAO.

Dr. Mizoguchi is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.